The new Open Research Europe (ORE) platform – funded by the European Commission – is now up and running.
Due to promising results, Porvair Sciences has agreed with its collaborative partners to make additional investment in the CEAT project which aims to dramatically improve the diagnosis and treatment of ovarian cancer.
UK-based Mogrify has secured the assignment of the foundational intellectual property (IP) underpinning its core direct cell conversion technology (Mogrify V1) and extended the method to allow for the inclusion of new sources of data and more accurate transcription factor predictions (Mogrify V2). The expansion of rights allows the Company to bring the latest version […]
Novigenix SA Switzerland, a pioneer in immuno-transcriptomics for precision medicine, will lead a consortium, including PamGene International and Radboud University (The Netherlands), to develop a blood based multi-omics test to predict response to immune checkpoint inhibitors in cancer. The consortium has been awarded a grant up to €1 million under the Eurostars programme.
Dutch biotech company Pepscope, offering endogenous protein kinase activity profiling technologies, has secured €4.3 million funding to further develop and commercialize their lead product QuantaKinome.
Switzerland-based RetinAI Medical will collaborate with Novartis Pharma in a multi-year agreement which will see RetinAI’s artificial intelligence tools employed to support multiple projects in ophthalmology. Both companies have previously worked successfully on pilot projects in this disease area.
SYNLAB, the leading medical diagnostic services provider in Europe, has agreed to sell its Analytics & Services (A&S) unit to SGS, the world’s leading inspection, verification, testing and certification company. The proceeds of the sale will remain in the group for future use.
Fluorescence microscopy is widely used in biochemistry and life sciences because it allows scientists to directly observe cells and certain compounds in and around them. Fluorescent molecules absorb light within a specific wavelength range and then re-emit it at the longer wavelength range. However, the major limitation of conventional fluorescence microscopy techniques is that the […]
A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat Covid-19. Haiping Zhang of the Shenzhen Institutes of Advanced Technology in Shenzhen, China, and colleagues present these findings.
Dr. Michael Teitell is director of the UCLA Jonsson Comprehensive Cancer Center. Scientists from the UCLA Jonsson Comprehensive Cancer Center have developed a simple, high-throughput method for transferring isolated mitochondria and their associated mitochondrial DNA into mammalian cells. This approach enables researchers to tailor a key genetic component of cells, to study and potentially treat […]
March 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.